Global Biopharmaceuticals Market Insights, Forecast to 2025

SKU ID : QYR- 13187375

Publishing Date : 05-Mar-2019

No. of pages : 119

PRICE
3900
7800

  • A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
    It is costly to discover and develop new drugs/medicines due to expensive research processes, Costs associated with clinical trials, resource-intensive approval procedures and costs associated
    With manufacturing (if the trials are successful).
    An additional point is that European R&D costs are higher than in other world regions due to the fragmented European patent system. The implications of a fragmented patent system in Europe include high uncertainty, quality drop and prohibitive costs, which are at least four times higher than in the US, China and South Korea thus constituting a financial burden on especially small biopharmaceutical enterprises in Europe (van Pottelsberghe 2009).
    The global Biopharmaceuticals market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biopharmaceuticals market based on company, product type, end user and key regions.

    This report studies the global market size of Biopharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biopharmaceuticals in these regions.
    This research report categorizes the global Biopharmaceuticals market by top players/brands, region, type and end user. This report also studies the global Biopharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

    The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Roche
    Amgen
    AbbVie
    Sanofi-Aventis
    Johnson & Johnson
    Pfizer
    Novo Nordisk
    Eli Lilly
    Novartis
    Merck

    Market size by Product
    Monoclonal Antibodies
    Interferon
    Colony-Stimulating Factor
    Erythropoietin
    Insulin
    Vaccines
    Growth Hormones
    Others
    Market size by End User
    Tumor
    Diabetes
    Cardiovascular
    Hemophilia
    Others

    Market size by Region
    North America
    United States
    Canada
    Mexico
    Asia-Pacific
    China
    India
    Japan
    South Korea
    Australia
    Indonesia
    Singapore
    Malaysia
    Philippines
    Thailand
    Vietnam
    Europe
    Germany
    France
    UK
    Italy
    Spain
    Russia
    Central & South America
    Brazil
    Rest of Central & South America
    Middle East & Africa
    GCC Countries
    Turkey
    Egypt
    South Africa

    The study objectives of this report are:
    To study and analyze the global Biopharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Biopharmaceuticals market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Biopharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Biopharmaceuticals submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

    In this study, the years considered to estimate the market size of Biopharmaceuticals are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

    This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biopharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports